Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation

Leukemia Research

Volumn 34, Issue 9, 2010, Pages 1158-1168

  Li, Qing ^a   Zhai, Zhimin ^a   Xu, Xiucai ^a   Shen, Yuanyuan ^a   Zhang, Aimei ^a   Sun, Zimin ^b   Liu, Huilan ^b   Geng, Liangquan ^b   Wang, Yiping ^c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acute and chronic GVHD; AHSCT; Regulatory T cells

Indexed keywords

BUSULFAN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CD4 CD8 RATIO; CD4+ CD25+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; WHOLE BODY RADIATION;

EID: 77955266744     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.03.017     Document Type: Article

References (32)

1. Iwasaki T. Recent advances in the treatment of graft-versus-host disease. Clin Med Res 2004, 2(4):243-252.
2. Przepiorka D., Anderlini P., Saliba R., Cleary K., Mehra R., Khouri I., et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001, 98(6):1695-1700.
3. Przepiorka D., Smith T.L., Folloder J., Khouri I., Ueno N.T., Mehra R., et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999, 94(4):1465-1470.
4. Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., Seligsohn U. Williams hematology [B] 2001, 209-248. Mc Graw-Hill Press, New York. 6th ed.
5. Horowitz M.M., Gale R.P., Sondel P.M., Goldman J.M., Kersey J., Kolb H.J., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990, 75(3):555-562.
6. Krenger W., Ferrara J.L. Graft-versus-host disease and the Th1/Th2 paradigm. Immunol Res 1996, 15(1):50-73.
7. Taylor P.A., Noelle R.J., Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001, 193(11):1311-1318.
8. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001, 166(6):3789-3796.
9. + T cells with graft-versus-host disease after donor lymphocyte infusions. Haematologica 2005, 90(10):1389-1395.
10. Hess A.D. Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 2006, 12(1 Suppl. 2):13-21.
11. Hoffmann P., Ermann J., Edinger M., Fathman C.G., Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002, 196(3):389-399.
12. + immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant 2002, 8(10):525-535.
13. + immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J Immunol 2006, 176(2):1266-1273.
14. Przepiorka D., Weisdorf D., Martin P., Klingemann H.G., Beatty P., Hows J., et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15(6):825-828.
15. Akpek G., Lee S.J., Flowers M.E., Pavletic S.Z., Arora M., Lee S., et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003, 102(3):802-809.
16. O'Donnell P.V., Luznik L., Jones R.J., Vogelsang G.B., Leffell M.S., Phelps M., et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2002, 8(7):377-386.
17. Terabe M., Berzofsky J.A. Immunoregulatory T cells in tumor immunity. Curr Opin Immunol 2004, 16(2):157-162.
18. + T regulatory cells in humans. Hum Immunol 2005, 66(1):13-20.
19. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203(7):1693-1700.
20. Cohen J.L., Trenado A., Vasey D., Klatzmann D., Salomon B.L. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002, 196(3):401-406.
21. high T-regulatory cells in recipients and their corresponding donors to acute GVHD. Transpl Int 2007, 20(5):440-446.
22. Miura Y., Thoburn C.J., Bright E.C., Phelps M.L., Shin T., Matsui E.C., et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004, 104(7):2187-2193.
23. Arimoto K., Kadowaki N., Ishikawa T., Ichinohe T., Uchiyama T. FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation. Int J Hematol 2007, 85(2):154-162.
24. + regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005, 106(8):2903-2911.
25. high regulatory T cells. Blood 2004, 103(6):2410-2416.
26. Sackstein R. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease. Biol Blood Marrow Transplant 2006, 12(1 Suppl. 1):2-8.
27. Ju X., Wang J. Roles of cytokines in acute graft-versus-host disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2000, 8(4):312-316.
28. Remberger M., Jaksch M., Uzunel M., Mattsson J. Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation. Eur J Haematol 2003, 70(6):384-391.
29. Hirokawa M., Takatsu H., Niitsu H., Nishinari T., Nimura T., Itoh T., et al. Serum tumor necrosis factor-alpha levels in allogeneic bone marrow transplant recipients with acute leukemia. Tohoku J Exp Med 1989, 159(3):237-244.
30. - T cells to acquire regulatory cell function. Blood 2003, 101(12):5076-5083.
31. Lunn R.A., Sumar N., Bansal A.S., Treleaven J. Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease. Hematology 2005, 10(2):107-114.
32. Liem L.M., Fibbe W.E., van Houwelingen H.C., Goulmy E. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation 1999, 67(1):59-65.